Back

Who should be treated with an SGLT2 inhibitor?

30 August 2021 (08:00 - 08:11)
Organised by:
Congress Presentation Part of: Everything you need to know about SGLT2 inhibitors in heart failure Chronic Heart Failure ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors in heart failure: do I have to worry about the kidneys?
Associate Professor K. Damman (Groningen, NL)
Slides Video
Presentation thumbnail
SGLT2 inhibitors in heart failure: adjusting other treatments and what to tell the patient.
Professor A. Cahn (Jerusalem, IL)
Slides Video
Presentation thumbnail
Everything you need to know about SGLT2 inhibitors in heart failure – discussion.

Access the full session

Session thumbnail
Everything you need to know about SGLT2 inhibitors in heart failure
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources